$IRS

IRSA to Pay Second Interest Installment on 2035 Series XXIV Notes on March 31, 2026

IRSA Inversiones y Representaciones SA is set to pay its second interest installment of $19.22 million on its 8% fixed-rate Series XXIV notes due 2035 on March 31, 2026. The company holds $480.45 million in these notes, with no principal amortization occurring during this payment. Spark, TipRanks’ AI Analyst, rates IRSA stock as "Outperform" due to its solid financial performance, attractive valuation, and supportive earnings-call guidance, despite weak technicals.

Original reporting
TipRanks · TipRanks Auto-Generated Newsdesk
Published Mar 20, 2026, 6:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 20, 2026, 7:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
IRSA to Pay Second Interest Installment on 2035 Series XXIV Notes on March 31, 2026 — source image
Decision brief

The 30-second read

$IRSNeutralLow
01

Why it matters

Routine debt servicing generally indicates operational stability but warrants monitoring for broader financial health signals.

02

Market read

The news is of limited immediate trading relevance but provides insight into IRSA's debt management.

03

What to watch

Potential upcoming financial disclosures or macroeconomic factors could influence IRSA's performance beyond this interest payment.

Relevance 6/10Timing: short-term (within 1 month)

Background

IRSA is a prominent Argentine real estate company with debt obligations reflected in its notes.

Company-level read

Ticker impact

$IRSNeutralMedium confidence
Context

The news pertains directly to IRSA Inversiones y Representaciones SA, focusing on its upcoming interest payment on its debt notes.

Expected impact

Minimal immediate impact on stock price; potential for slight positive sentiment due to timely debt servicing.

Evidence & confidence

Interest payments are routine financial obligations; unless accompanied by news of financial distress, they typically do not cause significant stock price movements.

Market effects

The real estate and finance sectors may experience minor sentiment shifts due to debt servicing news.

Limited regional impact; specific to Argentine real estate and finance markets.

Low; the event is company-specific and routine.

Counterpoint

Some investors might interpret the scheduled interest payment as a sign of stable cash flow, potentially supporting a positive outlook.

Key entities

  • IRSA Inversiones y Representaciones SA

    A leading Argentine real estate and investment firm.

Related articles

$IRSMed

IRSA Inversiones y Representaciones S.A announces its results for the first quarter of Fiscal Year 2027 ended September 30, 2026

IRSA Inversiones y Representaciones S.A. reported a net loss of ARS 6,380 million for Q1 FY2027, down from a gain of ARS 217,952 million in the same period last year, due to fair value changes in investment properties. Adjusted EBITDA from rental segments decreased by 2.0%, while total Adjusted EBITDA increased by 9.3%. The company announced a cash dividend of ARS 211,000 million, representing a 10.8% yield.

$IRSMedAI 8/10

IRSA Inversiones y Representaciones SA (IRS) (Q4 2026) Earnings Call Highlights: Record

IRSA Inversiones y Representaciones SA (IRS) reported Q4 2026 earnings with mixed results. Tenant sales in shopping malls fell 8.6% due to Argentina's challenging consumption environment. EBITDA margins slightly decreased, and Banco Hipotecario, in which IRS holds a 29% stake, faced increased NPLs. The company expects $150M in CapEx for 2027, potentially increasing net debt. IRS may consider a new share repurchase program and maintains a flexible dividend policy, with $390M in cash. Management d

Med

IRSA INVESTMENTS & REPRESENTATIONS INC (IRS): Financial results for FY2026

IRSA INVESTMENTS & REPRESENTATIONS INC (IRS) furnished an SEC Form 6-K — earnings release. Yes ☐ No x IRSA INVERSIONES Y REPRESENTACIONES SOCIEDAD ANÓNIMA (THE “COMPANY”) REPORT ON FORM 6-K By letter dated September 3, 2026, the Company reported that in compliance with Section 62 of the Regulations issued by the Buenos Aires Stock Exchange, this is to report the follow

$ONCYMedAI 8/10

ONCOLYTICS BIOTECH INC (ONCY): Translational Data from Anal Cancer Patients Show Pelareorep Drives HPV-Specific Immune Responses, Supporting its Potential Across HPV-Driven Cancers

ONCOLYTICS BIOTECH INC (ONCY) filed an SEC Form 8-K — Other Events. Translational Data from Anal Cancer Patients Show Pelareorep Drives HPV-Specific Immune Responses, Supporting its Potential Across HPV-Driven Cancers Pelareorep-driven changes in the tumor microenvironment are associated with tumor responses and shrinkage Immune activation levels